Association Between Immune-Related Adverse Events and Survival in Patients With Solid Tumors Treated With ICIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Treatment Reviews
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias
Cancer Treat. Rev 2022 Nov 01;110(xx)102452, M Kfoury, M Najean, A Lappara, AL Voisin, S Champiat, JM Michot, S Laghouati, C Robert, B Besse, JC Soria, O Lambotte, C Massard, A Marabelle, M TexierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.